Bo Feldt-Rasmussen

Bo Feldt-Rasmussen

Klinisk Professor


  1. 2013
  2. Udgivet

    Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease. / Idorn, Thomas; Knop, Filip K; Jørgensen, Morten; Holst, Jens Juul; Hornum, Mads; Feldt-Rasmussen, Bo.

    I: Kidney International, Bind 83, Nr. 5, 05.2013, s. 915-23.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  3. Udgivet

    Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease : protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study. / Idorn, Thomas; Knop, Filip K; Jørgensen, Morten; Jensen, Tonny; Resuli, Marsela; Hansen, Pernille M; Christensen, Karl B; Holst, Jens Juul; Hornum, Mads; Feldt-Rasmussen, Bo.

    I: B M J Open, Bind 3, Nr. 4, e002764, 26.04.2013, s. 1-10.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  4. Udgivet

    Diagnosis, management and treatment of glucometabolic disorders emerging after kidney transplantation. / Hornum, Mads; Lindahl, Jørn P; von Zur-Mühlen, Bengt; Jenssen, Trond; Feldt-Rasmussen, Bo.

    I: Transplant International, Bind 26, Nr. 11, 2013, s. 1049-1060.

    Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

  5. Udgivet

    Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with type 2 diabetes at 10 years of follow-up. / Svendstrup, Mathilde; Christiansen, Merete Skovdal; Magid, Erik; Hommel, Eva; Feldt-Rasmussen, Bo.

    I: Journal of Diabetes and its Complications, Bind 27, Nr. 6, 2013, s. 570-5.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

ID: 923040